Neuca

Neuca Interest Coverage

The Interest Coverage Ratio of Neuca (NEU.WA) as of Oct 21, 2026 is 6.49. In the previous year, Interest Coverage Ratio was 6.32 — a change of 2.77% (higher).

Interest Coverage

6.49

YoY

2.77%

Last updated:

Interest Coverage Ratio of Neuca is 2024 6.49 . Interest Coverage Ratio of Neuca was 2023 6.32 . It decreases by 2.77% higher compared to the previous year.

The Neuca Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
56.23 PLN
Jan 1, 2018
16.69 PLN
Jan 1, 2019
28.91 PLN
Jan 1, 2020
7.81 PLN
Jan 1, 2021
501.37 PLN
Jan 1, 2022
7.54 PLN
Jan 1, 2023
6.32 PLN
Jan 1, 2024
6.49 PLN
The Neuca Interest Coverage history
YEARInterest CoverageYoY
6.49+2.77%
6.32-16.20%
7.54-98.50%
501.37+6,316.84%
7.81-72.98%
28.91+73.27%
16.69-70.33%
56.23-20.48%
70.72+53.65%
46.03+105.16%
22.43—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Interest Coverage Ratio of Neuca is 6.49 in 2024.

Interest Coverage Ratio of Neuca changed from 6.32 to 6.49, representing a 2.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Neuca since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Neuca with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Neuca

All Key Metrics — Neuca